PhRMA spokesman snaps at teen reporter in Savannah

Share this article:

Montel Williams, the talk-show host and spokesman for PhRMA's Partnership for Prescription Assistance, lashed out at a 17-year-old intern from a Savannah, GA, newspaper at an event for the patient assistance program.

In a videotaped interview Friday at the Westin Savannah Harbor, the Savannah Morning News intern asked Williams if he thought pharma companies would cut R&D if their profits were restricted – a question she'd come up with in discussion with her AP English teacher. Williams, she reported, said: “I'm trying to figure out exactly why you are here and what the interview is about.” After asking her if she suffered from any illness, he added: “I'm here as a patient advocate talking about the fact that medications available today are saving people's lives, that's what saving mine and after that, this interview is done.”
With that, The Savannah Morning News reported, Williams snapped his fingers and stalked off. But later, as the intern and her colleagues were setting up for an unrelated assignment at the same hotel, Williams spotted her and, the paper's web content producer said, “walked up with his bodyguard and got in [her] face pointing his finger and telling her, ‘Don't look at me like that. Do you know who I am? I'm a big star, and I can look you up, find where you live and blow you up.'”

Later that day, Williams issued a statement apologizing for what he characterized as a “misunderstanding.” “I mistakenly thought the reporter and photographer in question were at the hotel to confront me about some earlier comments. I was wrong and I apologize for my overreaction.”

PhRMA SVP Ken Johnson told the paper that Williams, who suffers from multiple sclerosis, thought the newspaper crew was there to provoke him, but was wrong to blow his stack. “Most people have no idea of the pain he suffers because of MS,” said Johnson. “But even on bad days, bad behavior is not acceptable.”

Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...